Clinical study for advanced or metastatic soft tissue sarcoma of non-extremities treated with doxorubicin-based chemotherapy (a retrospective study)

Clinical study for advanced or metastatic soft tissue sarcoma of non-extremities treated with doxorubicin-based chemotherapy (a retrospective study) - Clinical study for advanced or metastatic soft tissue sarcoma of non-extremitie

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000028787

Enrollment

Registered

2017-08-23

Start date

2017-05-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metastatic soft tissue sarcoma of non-extremities treated with doxorubicin-based chemotherapy in our institution

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with metastatic soft tissue sarcoma of non-extremities who were treated with doxorubicin based chemotherapy between October 2015 and April 2016 in our institution

Exclusion criteria

Exclusion criteria: not applicable

Design outcomes

Primary

Measure	Time frame
Overall survival for the patients with metastatic soft tissue sarcoma of non-extremities who were treated with doxorubicin based chemotherapy	—

Countries

Japan

Contacts

Public ContactShoko Marshall

Cancer Institute Hospital of Japanese Foundation for Cancer Research Department of Medical Oncology

shoko.masharu@jfcr.or.jp+81-3-3520-0111

Outcome results